- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Breastmilk sugars could help treat infections and prevent preterm births
Overview
Breastfeeding has long been used as a method to help keep newborns healthy and protected against a variety of diseases. But certain sugars naturally found in breastmilk could also help prevent infections before a baby arrives. Researchers reporting in ACS Central Science have found that these sugars can stop a common prenatal infection in human tissues and pregnant mice. This could someday help avoid preterm births or complications without the need for additional antibiotics.
One of the most common bacteria that can affect pregnancies is Group B streptococcus (GBS). If left untreated, GBS infections can potentially lead to adverse effects, including neonatal pneumonia or preterm birth. Though treatments are available, they primarily rely on antibiotics, which can give rise to resistant strains. However, many of the compounds already present in human breast milk, such as human milk oligosaccharides (HMOs), naturally have antibacterial effects. The team wanted to investigate HMO activity in GBS infections in pregnant mice and human tissues.
The team first analyzed the protective effects of HMOs on human tissue infected with GBS, using both ex vivo fetal tissues and an organoid model of the vagina. When they added a mixture of HMOs designed to mimic the sugar composition in breast milk, the bacteria could not adhere and form colonies. The HMO mixture was then tested in pregnant mice infected with GBS. The treated mice had a relatively typical level of inflammation, reduced numbers of bacteria in several reproductive tissues, and experienced no instances of preterm births, ruptured membranes or maternal deaths.
Reference: The Utility of Human Milk Oligosaccharides Against Group B Streptococcus Infections of Reproductive Tissues and Cognate Adverse Pregnancy Outcomes, ACS Central Science; DOI 10.1021/acscentsci.3c00101
Speakers
Isra Zaman
B.Sc Life Sciences, M.Sc Biotechnology, B.Ed